MetaCap

BioAge Labs Statistics

NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.28-0.43 (-9.13%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioAge Labs by the numbers

BioAge Labs has a market capitalization of $196.7 million based on 45.95M shares outstanding. With trailing EPS of $-2.56, BioAge Labs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.7% below its 50-day average and 71.0% below its 200-day average.

Average daily trading volume is 740.06K shares, or about $3.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BIOA valuation vs. peer median

BIOA compared with the median of 8 peer companies
MetricBIOAPeer medianDifference
Market cap$196.67M$197.54M-0%
Avg. volume740.06K244.05K+203%

Peer median across 8 companies: YARW, NGEN, ACIU, ANTX, DRUG, BCYC, FTH, RNAC.

Valuation

Market cap
$196.67M
Price / sales (latest FY)
21.86
EPS (TTM)
$-2.56

Price and trading

Previous close
4.71
Open
4.60
Day range
4.24 – 4.77
52-week range
4.24 – 25.96
52-week change
-50.52%
Beta
—
Volume
632.10K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
196.67M
Forward Pe
-1.59
Eps
-2.56
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
25.96
Week52 Low
4.24
Avg Volume
740.06K
Shares Outstanding
45.95M
Ma50
6.18
Ma200
14.74
Earnings Date
Nov 5, 2026
Pct From52w High
-83.51%
Pct From52w Low
1.06%

Related